First Adult Stem Cell Human Trial For Spinal Cord Injury Underway

RNL Bio located in Korea has already launched commercial stem cell therapy for pets like dogs and cats with spinal cord injury since 2008. Now they have announced they are beginning trials of the same treatment on humans. On April 30th the Korean FDA approved its human clinical study to treat patients with spinal cord injury using their product ‘RNL-Astrostem’ that is based on fat derived adult stem cells.

In early 2009 the U.S. FDA permitted Geron Corp to conduct a clinical trial using embryonic stem cells to treat patients with spinal cord injuries. However the RNL Bio method may prove less controversial due to using adult stem cells.

RNL-Astrostem is administered by intravenous infusion so patients don’t have to worry about any invasive and painful surgical procedure. Dr. Jeong Chan Ra, CEO of the firm, said “Our stem cell therapeutics involves no immune rejection because the stem cells are exactly patients own. Our adult stem cell has no tumorigenicity activity at all while embryonic stem cell faces high risk of it. We have developed safest therapeutics to help devastated patients with incurable diseases."

Based on press release from PRLOG

Discuss this article

Name Email Message Enter code

Posts in discussion

Posted: 1 year, 8 months ago by from Andy #383

here is the article- Andy

Read More...